Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) assessment for Her-2 status in breast cancer

被引：0
|
作者：
Weiguo Sui
Minglin Ou
Jiejing Chen
Youhua Wan
Hongbo Peng
Minfang Qi
He Huang
Yong Dai
机构：
[1] 181st Hospital of People's Liberation Army,Laboratory Center of Guangzhou Military Area Command
[2] Guangxi Normal University,College of Life Science
[3] 181st Hospital of People's Liberation Army,Pathology Department of Guangzhou Military Area Command
来源：
World Journal of Surgical Oncology | / 7卷
关键词：
Trastuzumab; Human Epidermal Growth Factor Receptor; Invasive Ductal Carcinoma; Herceptin; Discordance Rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Choice of primary anti-HER2 antibody affects concordance of immunohistochemistry (IHC) with fluorescence in situ hybridization (FISH) for determination of breast cancer HER2 status
    Gown, A. M.
    Goldstein, L. C.
    Barry, T. S.
    Kandalaft, P. L.
    Kussick, S. J.
    Tse, C. C.
    LABORATORY INVESTIGATION, 2008, 88 : 33A - 34A
  • [42] Choice of primary Anti-HER2 antibody affects concordance of immunohistochemistry (IHC) with fluorescence in situ hybridization (FISH) for determination of breast cancer HER2 status
    Gown, A. M.
    Goldstein, L. C.
    Barry, T. S.
    Kandalaft, P. L.
    Kussick, S. J.
    Tse, C. C.
    MODERN PATHOLOGY, 2008, 21 : 33A - 34A
  • [43] The role of immunohistochemistry and fluorescence in situ hybridization for HER-2/neu in assessing the prognosis of breast cancer
    Mitchell, MS
    Press, MF
    SEMINARS IN ONCOLOGY, 1999, 26 (04) : 108 - 116
  • [44] HER2 amplification: Correlation of chromogenic in situ hybridization (CISH) with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Wixom, CR
    Albers, EA
    Weidner, N
    LABORATORY INVESTIGATION, 2003, 83 (01) : 51A - 51A
  • [45] Her-2neu/evaluation in breast cancer: A comparison of immunohistochemical (IHC) determination and fluorescence in situ hybridization (FISH).
    Mehta, A
    Mahadevia, S
    Cannizzaro, L
    Ramesh, KH
    Fineberg, S
    LABORATORY INVESTIGATION, 2001, 81 (01) : 32A - 32A
  • [46] Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice
    Dolan, M
    Snover, D
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (05) : 766 - 770
  • [47] Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice
    Egervari, K
    Szollosi, Z
    Nemes, Z
    Kaczur, V
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 125 (01) : 155 - 156
  • [48] Discordance Between HER-2/NEU Expression Assessed Using Immunohistochemistry (IHC) and Fluorescence in Situ Hybridization (FISH): Is It Important to Detect?
    Duman, Berna Bozkurt
    Sahin, Berksoy
    Kara, Ismail Oguz
    Erkisi, Melek
    Kidik, Adem
    CUKUROVA MEDICAL JOURNAL, 2014, 39 (01): : 53 - 60
  • [49] HER-2/neu analysis in archival tissue samples of human breast cancer:: Comparison of immunohistochemistry and fluorescence in situ hybridization
    Lebeau, A
    Deimling, D
    Kaltz, C
    Sendelhofert, A
    Iff, A
    Luthardt, B
    Untch, M
    Löhrs, U
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 354 - 363
  • [50] Assessment of Real World HER2 Status by Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) in Breast Cancers: Comparison with HERmark, a Validated Quantitative Measure of HER2 Protein Expression.
    Huang, W.
    Paquet, A.
    Sivaraman, S.
    Pesano, R.
    Goodman, L.
    Sherwood, T.
    Lie, Y.
    Hickey, J.
    Walworth, C.
    Haddad, M.
    Andersonl, S.
    Bates, M.
    Weidler, J.
    CANCER RESEARCH, 2011, 71
12345